Wart Remover

Manufacturer
Pharmaplast SAE
Effective date
2025-01-07
Label type
HUMAN OTC DRUG LABEL
Version
4
Source
full-release
Hydrated at
2026-06-01 00:52:12

Label at a glance#

ProductWart Remover
Active ingredientSALICYLIC ACID
Label structure8 sections

Dosage and administration

For removal of Common and Plantar warts: Wash affected area. May soak wart in warm water for 5 minutes. Dry area thoroughly. Cut plaster to fit wart. Apply medicated plaster. Repeat procedure every 48 hours as needed (until wart is removed) for up to 12 weeks.

Label contents#

Full prescribing information#

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Salicylic acid 40% in a plaster vehicle

Purpose

OTC - PURPOSE SECTION

Wart remover adhesive pads

Indications:

INDICATIONS & USAGE SECTION

  • For the removal of common warts. The common wart is easily recognized by the rough 'cauliflower-like' appearance of the surface.
  • For the removal of plantar warts on the bottom of the foot.
    The plantar wart is recognized by its location only on the bottom of the foot, its tenderness, and the interruption of the footprint pattern.

Warnings

WARNINGS SECTION

  • For external use only
  • Do not use this product on irritated skin, on any area that is infected or reddened, if you are a diabetic, or if you have poor blood circulation.
  • If discomfort persists, see your doctor.
  • Do not use on moles, birthmarks, warts with hair growing from them, genital warts, or warts on the face or mucous membranes.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

  • Keep out of reach of children.

Directions

DOSAGE & ADMINISTRATION SECTION

For removal of Common and Plantar warts:

  • Wash affected area.
  • May soak wart in warm water for 5 minutes.
  • Dry area thoroughly.
  • Cut plaster to fit wart.
  • Apply medicated plaster.
  • Repeat procedure every 48 hours as needed (until wart is removed) for up to 12 weeks.

Inactive ingredient

INACTIVE INGREDIENT SECTION

Pressure sensitive adhesive fabric

Packaging

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

LabelLabel

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
240559salicylic acid 40 % Medicated PatchPSN4
240559salicylic acid 0.4 MG/MG Medicated PatchSCD4
240559salicylic acid 40 % Medicated PatchSY4

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
28691-0400-1Wart Remover20 in 1 BOXPLASTER204
28691-0400-2Wart Remover10 in 1 BOXPLASTER104

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
28691-0400WART REMOVER (SALICYLIC ACID) PLASTER [PHARMAPLAST SAE]4Current NDC, Legacy NDC, 2 package rows20250112_a581fcf8-b406-48af-b358-87531e3486a2.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 6 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
28691-040028691-0400-1, 28691-0400-2

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 5 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Wart RemoverSALICYLIC ACIDPharmaplast SAEa581fcf8-b406-48af-b358-87531e3486a22025-01-07WarningsExact identifier
ndc (package): 28691-0400-1
ndc (package): 28691-0400-2
ndc (product): 28691-0400
ndc11 (package): 28691040001
ndc11 (package): 28691040002
spl id: 7db1e498-60c6-48b4-ae6b-f2e338bad7a1
spl set id: a581fcf8-b406-48af-b358-87531e3486a2

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.